National Penn Investors Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	$304K	Buy	4,545 +1,018	+29%	+$68.1K	0.04%	170
2015 Q4	$239K	Buy	+3,527	New	+$239K	0.03%	193
2015 Q3	–	Sell	-3,342	Closed	-$210K	–	222
2015 Q2	$210K	Buy	+3,342	New	+$210K	0.02%	214